(Q34627103)

English

Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

Ângela M. Carneiro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Manuel S. Falcão

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Fernando Faria-Correia

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Fernando Falcao-Reis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Daniel Barthelmes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Luis S Mendonça

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Rita M Gonçalves

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

18 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

225

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

211-221

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

The epidemiology of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Retinal angiogenesis in development and disease

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Targeting VEGF-A to treat cancer and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Vascular events in patients with age-related macular degeneration treated with intraocular bevacizumab.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Age-related macular degeneration and risk for stroke

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Age-related macular degeneration and mortality from cardiovascular disease or stroke

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Is age-related macular degeneration associated with stroke among elderly americans?

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

A prospective study of blood pressure and intraocular pressure changes in hypertensive and nonhypertensive patients after intravitreal bevacizumab injection.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

First diabetes prevalence study in Portugal: PREVADIAB study

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Prospective community-based study of stroke in Northern Portugal: incidence and case fatality in rural and urban populations

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Adherence to the Southern European Atlantic Diet and occurrence of nonfatal acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Ten-year fatal and non-fatal myocardial infarction incidence in elderly populations in Spain: the EPICARDIAN cohort study

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Body mass index and the incidence of visually significant age-related maculopathy in men

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells.

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Bevacizumab treatment for cancer patients with cardiovascular disease: a double edged sword?

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

1 reference

https://api.crossref.org/works/10.1159%2F000323943

21 January 2018

Identifiers

10.1159/000323943

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34627103&oldid=2043615918"